<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">In view of lack of robust evidence for either benefit or harm, it is reasonable for patients to continue using ACE inhibitors and ARB, as recommended by European Society of Cardiology Council on Hypertension, European Society of Hypertension and American Heart Association [
 <xref rid="bib28" ref-type="bibr">[28]</xref>, 
 <xref rid="bib29" ref-type="bibr">[29]</xref>, 
 <xref rid="bib30" ref-type="bibr">[30]</xref>].
</p>
